NeuroOne Medical Technologies Corporation APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
NeuroOne Medical Technologies Corporation (NMTC) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $352.78 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $352.78K, a 11.41% increase year-over-year.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $342.13K, a 36.76% increase year-over-year.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-12-31 was $359.25K, a 5.90% increase year-over-year.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $316.65K, a 6.48% decline year-over-year.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $1.34M, a 21.62% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $1.11M, a 16.71% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $947.21K, a 47.18% decline from fiscal 2021.
- NeuroOne Medical Technologies Corporation apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $1.79M, a 124.64% increase from fiscal 2020.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $352.78K 10-Q · filed 2026-08-13 | $694.91K derived: sum of 2 quarters · filed 2026-08-13 | $1.05M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2026-03-31 | $342.13K 10-Q · filed 2026-08-13 | $701.39K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $359.25K 10-Q · filed 2026-08-13 | |||
| 2025-06-30 | $316.65K 10-Q · filed 2026-08-13 | $566.82K derived: sum of 2 quarters · filed 2026-08-13 | $906.05K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-03-31 | $250.17K 10-Q · filed 2026-08-13 | $589.39K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2024-12-31 | $339.22K 10-Q · filed 2026-08-13 | |||
| 2024-09-30 | $1.34M 10-K · filed 2024-12-17 | |||
| 2024-06-30 | $338.61K 10-Q · filed 2024-08-14 | $695.47K derived: sum of 2 quarters · filed 2025-05-13 | $1.00M derived: sum of 3 quarters · filed 2025-05-13 | |
| 2024-03-31 | $356.86K 10-Q · filed 2025-05-13 | $665.50K derived: sum of 2 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $308.64K 10-Q · filed 2025-05-13 | |||
| 2023-09-30 | $1.11M 10-K · filed 2024-12-17 | |||
| 2023-06-30 | $296.40K 10-Q · filed 2024-08-14 | $534.03K derived: sum of 2 quarters · filed 2024-08-14 | $834.21K derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | $237.63K 10-Q · filed 2024-08-14 | $537.81K derived: sum of 2 quarters · filed 2024-08-14 | ||
| 2022-12-31 | $300.18K 10-Q · filed 2024-08-14 | |||
| 2022-09-30 | $947.21K 10-K · filed 2023-12-15 | |||
| 2022-06-30 | $255.55K 10-Q · filed 2023-08-14 | $488.26K derived: sum of 2 quarters · filed 2023-08-14 | $691.34K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $232.72K 10-Q · filed 2023-08-14 | $435.79K derived: sum of 2 quarters · filed 2023-08-14 | ||
| 2021-12-31 | $203.07K 10-Q · filed 2023-08-14 | |||
| 2021-09-30 | $1.79M 10-K · filed 2022-12-22 | |||
| 2021-06-30 | $878.85K 10-Q · filed 2022-08-11 | $1.21M derived: sum of 2 quarters · filed 2022-08-11 | $1.45M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $326.36K 10-Q · filed 2022-08-11 | $572.19K derived: sum of 2 quarters · filed 2022-08-11 | ||
| 2020-12-31 | $245.83K 10-Q · filed 2022-08-11 | |||
| 2020-09-30 | $798.24K 10-K/A · filed 2022-05-31 | |||
| 2020-06-30 | $104.00K 10-Q · filed 2021-08-13 | $192.80K derived: sum of 2 quarters · filed 2021-08-13 | $655.89K derived: sum of 3 quarters · filed 2021-08-13 | |
| 2020-03-31 | $88.81K 10-Q · filed 2021-08-13 | $551.89K derived: sum of 2 quarters · filed 2021-08-13 | ||
| 2019-12-31 | $463.08K 10-Q · filed 2021-08-13 | $463.08K 10-Q · filed 2021-02-16 | ||
| 2019-09-30 | $324.20K 10-K · filed 2020-12-09 | |||
| 2018-09-30 | $5.47K 10-KT · filed 2019-03-18 | |||
| 2017-12-31 | $69.57K 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |